Harvest One to Acquire Dream Water
Harvest One to Acquire Dream Water
Perth, May 4, 2018 AEST (ABN Newswire) - Harvest One to acquire Dream Water MMJ PhytoTech Limited (ASX:MMJ) ("MMJ") is pleased to note the attached press release by Harvest One Cannabis Inc. (CVE:HVT) ("Harvest One") confirming that Harvest One has entered into definitive agreements to acquire Dream Water, a consumer goods business with operations in the United States and Canada. The acquisition will deliver to Harvest One a ready-made consumer goods marketing, distribution and product development division that is generating around $6 million of annual revenue from its current product lines.

Harvest One intends to expand the Dream Water brands and product lines into the cannabis base within federally regulated markets globally.

To view the Harvest One Release, please visit:
http://abnnewswire.net/lnk/WZ4BD9OZ


About Harvest One Cannabis Inc

Harvest One Capital Inc. (CVE:HVT) (OTCMKTS:HRVOF) (FRA:2CN) is a global cannabis company focused on delivering high quality, innovative cannabis products and technology to regulated markets around the world. Our shareholders have significant exposure to the entire cannabis value chain through three business units, with Harvest One serving as the parent company over horticultural arm United Greeneries and medical arm Satipharm AG. Harvest One's businesses are all strategically located in favourable jurisdictions with supportive regulatory frameworks in place. United Greeneries has a Canadian ACMPR cultivation and sales license, making Harvest One a unique global company with the capacity to commercially cultivate and sell medicinal grade cannabis in a federally regulated environment.

 



About MMJ PhytoTech Ltd

Phytotech Medical ASX:PYL

In October 2017, MMJ PhytoTech Limited (ASX:MMJ) announced its strategy to become an incubator for strategic investments across regulated jurisdictions globally covering the entire cannabis value chain.

Following the successful listing of United Greeneries Holdings Ltd ("United Greeneries") and Satipharm AG ("Satipharm") on the TSX-V through Harvest One Cannabis Inc. (CVE:HVT), MMJ has focused on the identification of a number of independent strategic investment opportunities that have the potential to deliver significant value to the Company's shareholders.

MMJ is actively pursuing early stage opportunities with the ability to deliver significant future revenue and the opportunity to provide dramatic global synergistic value as regulatory frameworks in key international markets continue to evolve. MMJ is targeting the full range of emerging cannabis-related sectors including healthcare products, technology, infrastructure, logistics, processing, cultivation, equipment, R&D, hemp food products and retail.

MMJ currently holds an equity stake of 53,333,333 shares in Harvest One, 100% ownership of Israeli-based R&D division PhytoTech Therapeutics Limited ("PTL") and strategic holdings in e-Sense Lab Limited (ASX:ESE) and private Canadian-based company WeedMe Inc.

      


Contact

Jason Conroy
Chief Executive Officer
jconroy@mmjphytotech.com.au



Related Companies

MMJ PhytoTech Ltd   
Harvest One Cannabis Inc

ABN Newswire This Page Viewed:  (Last 7 Days: 202) (Last 30 Days: 1579) 
ANALYTICS: LOGIN HERE

MMJ PhytoTech Ltd NEWS: RECENT VISITS (25721)

Research Report

Social Media